CBP Annual Report Shows Seizures of Fentanyl Precursors Surged 150% in 2024, Highlighting New Challenge
- The United States Customs and Border Protection (CBP) just released its annual report for fiscal year 2024, and the standout stat is a jaw-dropping 150% increase in seizures of fentanyl precursor chemicals at U.S. ports of entry, signaling a major shift in smuggling tactics.
- While total fentanyl pill seizures dropped 10% compared to 2023, traffickers are now importing raw precursor powders in bulk, bypassing the need to manufacture finished pills overseas—a trend that CBP says complicates interdiction efforts at the border.
- CBP officers also reported a 25% rise in seizures of other synthetic opioids, like nitazenes, which are 10 to 50 times more potent than fentanyl, often undetectable by standard field test kits.
- At the southern border, apprehensions of migrants dropped 12% year-over-year, but the number of unaccompanied minors crossing hit a record high for a single quarter, raising new humanitarian and resource allocation concerns.
- The digital front is also evolving: CBP processed over 2,000 advance cargo data submissions from e-commerce shipments in the past year, with lithium batteries and counterfeit electronics flagged as emerging smuggling vectors for precursor chemicals.